LHC Group, Inc. (LHCG) Position Lifted by Columbus Circle Investors

Columbus Circle Investors increased its holdings in shares of LHC Group, Inc. (NASDAQ:LHCG) by 48.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 81,152 shares of the health services provider’s stock after purchasing an additional 26,496 shares during the period. Columbus Circle Investors’ holdings in LHC Group were worth $8,358,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Oppenheimer Asset Management Inc. boosted its stake in LHC Group by 153.7% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 7,257 shares of the health services provider’s stock worth $748,000 after purchasing an additional 4,396 shares during the period. Russell Investments Group Ltd. boosted its stake in LHC Group by 16.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 279,530 shares of the health services provider’s stock worth $28,784,000 after purchasing an additional 38,629 shares during the period. Advisors Preferred LLC acquired a new stake in LHC Group during the 3rd quarter worth $319,000. First Trust Advisors LP boosted its stake in LHC Group by 70.8% during the 3rd quarter. First Trust Advisors LP now owns 64,061 shares of the health services provider’s stock worth $6,598,000 after purchasing an additional 26,555 shares during the period. Finally, First Citizens Bank & Trust Co. acquired a new stake in LHC Group during the 3rd quarter worth $204,000. Hedge funds and other institutional investors own 86.24% of the company’s stock.

In other news, COO Donald Dwayne Stelly sold 2,756 shares of the firm’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $99.32, for a total value of $273,725.92. Following the completion of the sale, the chief operating officer now owns 104,512 shares in the company, valued at approximately $10,380,131.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Jeff Reibel sold 1,921 shares of the firm’s stock in a transaction on Monday, August 20th. The stock was sold at an average price of $94.12, for a total transaction of $180,804.52. Following the completion of the sale, the senior vice president now owns 8,125 shares of the company’s stock, valued at approximately $764,725. The disclosure for this sale can be found here. 6.80% of the stock is currently owned by company insiders.



LHCG has been the subject of a number of recent research reports. SunTrust Banks increased their price target on shares of LHC Group to $115.00 and gave the stock a “buy” rating in a research note on Thursday, September 13th. BidaskClub cut shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, July 18th. Royal Bank of Canada increased their price target on shares of LHC Group to $101.00 and gave the stock a “sector perform” rating in a research note on Friday, August 3rd. Benchmark set a $110.00 price target on shares of LHC Group and gave the stock a “buy” rating in a research note on Thursday, August 2nd. Finally, Jefferies Financial Group increased their price target on shares of LHC Group to $120.00 and gave the stock a “buy” rating in a research note on Friday, August 3rd. Four equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. LHC Group currently has a consensus rating of “Buy” and a consensus price target of $103.00.

LHCG stock opened at $91.43 on Thursday. LHC Group, Inc. has a one year low of $58.65 and a one year high of $103.79. The firm has a market capitalization of $2.69 billion, a PE ratio of 37.78, a PEG ratio of 1.34 and a beta of 0.52. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.18.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, October 31st. The health services provider reported $0.95 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.95. LHC Group had a net margin of 3.75% and a return on equity of 8.33%. The company had revenue of $507.00 million during the quarter, compared to analysts’ expectations of $515.03 million. During the same quarter last year, the business earned $0.64 EPS. The business’s revenue was up 88.0% on a year-over-year basis. As a group, research analysts expect that LHC Group, Inc. will post 3.52 EPS for the current year.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Article: What is intrinsic value?

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply